Genencell founder sentenced to four years over clinical-trial solicitation
AI Summary- Seoul High Court sentenced Genencell founder Kang over clinical-trial solicitation and related financial offenses.
- 600 million Korean won paid to Yang was recognized as compensation for the solicitation.
- The appellate court reversed the first trial’s acquittal on the 600 million Korean won charge.